Tolerability and Pharmacokinetics(PK)/Pharmacodynamics(PD) Study of GW003 in Healthy Subjects

Clinical trial NCT02643901 · COMPLETED

Trial details

NCT number: NCT02643901
Sponsor: Jiangsu T-Mab Biopharma Co.,Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chemotherapy-induced Neutropenia

Start date: 2015-09-01
Primary completion: 2016-10-10
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.